ERYTHROPOIETIN - CLINICAL-APPLICATIONS

被引：7

作者：

FOA, P

机构：

[1] Istituto di Scicnze Mediche, Padiglione Granclli, Milano

来源：

ACTA HAEMATOLOGICA | 1991年 / 86卷 / 03期

关键词：

ANEMIA ASSOCIATED WITH CANCER; ANEMIA ASSOCIATED WITH MYELODYSPLASTIC SYNDROMES; ANEMIA OF AIDS; ANEMIA OF RENAL DISEASE; AUTOTRANSFUSION; ERYTHROPOIETIN; HEMATOPOIETIC GROWTH FACTORS;

D O I：

10.1159/000204826

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The last few years have seen an enormous increase in our knowledge on the haematopoietic growth factor erythropoietin (Epo), firstly with its purification and determination of its primary amino acid sequence, and more recently with the isolation of the Epo gene and its expression in mammalian cell lines. This review article summarizes the crucial biological features of Epo and critically examines the main results obtained in clinical trials on humans.

引用

页码：162 / 168

页数：7

共 87 条

[1]

ADAMSON JW, 1989, SEMIN HEMATOL, V26, P5

[2] RESPONSIVENESS OF BONE-MARROW ERYTHROPOIETIC STEM-CELLS (CFU-E AND BFU-E) TO RECOMBINANT-HUMAN-ERYTHROPOIETIN (RH-EP) INVITRO IN APLASTIC-ANEMIA AND MYELODYSPLASTIC SYNDROME [J].